Filomena Mazzeo1, Valeria Di Onofrio1
1University of Naples “Parthenope”, Department of Science and Technology, Naples, Italy
Sport, Drugs and Health promotion: Pharmacological and Epidemiological aspects
Sport Mont 2019, 17(2), 81-85 | DOI: 10.26773/smj.190614
Abstract
Sport activity, must be directed to the promotion of individual and collective health. Thus, there is no doubt that drugs and pharmacological nutriment have been used by sportsmen and women to improve his physical performance. Doping is defined as “use of substances or adoption of medical practices not justified by pathological conditions, aimed at improving competitive performance”. It occurs not only in professional sport, but also affects amateur athletes. The effects of the abuse of add-on substances or the intake of substances that alter the outcome of the competition are in the educational interest of the school and it is a problem concerning not only sports ethics, but also public health. Over time, doping has shown a great ability to discover and always use new substances and appropriated the new scientific discoveries. Unfortunately, new discoveries for the human health are been used in distorted way by the athletes. In fact, the athletes may be able to use gene therapy to re-engineer their bodies for better performances. Drugs dependence depends on several factors: the socio-environmental context of the subject and what effects have the substance in the body. The purpose of the study was to reviewed the use of performance-enhancing drugs in sport in relating to the protection of the healh of athletes. We focus our analysis on pharmacological and epidemiological issue.
Keywords
drugs, sport, ergogenic aids, health, prevention
View full article
(PDF – 123KB)
References
Beerens, A.M., Al Hadithy, A.F., Rots, M.G., & Haisma, H.J. (2003). Protein chain transduction domains and their utility in gene therapy. Curr Gene Ther, 3(5), 486-94.
Botrè, F (2008). New and old challenges of sport drug testing. J. Mass Spectrom, 43, 903-7. https://doi.org/10.1002/jms.1455
Catalano, O.A., Daye, D., Signore, A., Iannace, C., Vangel, M., Luongo, A., & Rosen, B.R. (2017). Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast. International Journal of Oncology, 51(1), 281-288. https://doi.org/10.3892/ijo.2017.4012
de Hon, O., Kuipers, H., & van Bottenburg, M. (2014). Prevalence of doping use in elite sports: A review of numbers and methods. Sports Medicine, 45(1), 57-69. https://doi.org/10.1007/s40279-014-0247-x
D’elia, F., Mazzeo, F., & Raiola, G. (2018). The core curriculum in the university training of the teacher of physical education in italy. Journal of Human Sport and Exercise, 13, S413-S420. https://doi.org/10.14198/jhse.2018.13.Proc2.25
Doessing, S. & Kjaer, M. (2005). Growth hormone and connective tissue in exercise. Scand J Med Sci Sports, 15(4), 202-10.
Dvorak, J., Baume, N., Botré, F., ... & Zorzoli, M. (2014). Time for change: a roadmap to guide the implementation of the World Anti Doping Code 2015. Br J Sport Med, 0, 1-6. https://doi.org/10.1136/bjsports-2014-093561.
Esseiva, P., Ioset, S., Anglada, F., Gaste, L., Ribaux, O., Margot, P., Gallusserb, A., Biedermannb, A., Spechtc, Y., & Ottinger, E. (2007). “Forensic drug intelligence: an important toll in law enforcement”. Forensic Sci. Int., 16, 247-54.
Gomez, J. (2005) Use of performance-enhancing substances. Pediatrics, 115(4),1103-6.
Illiano, M., Nigro, E., Sapio, L., Caiafa, I., Spina, A., Scudiero, O., Bianco, A., Esposito, S., Mazzeo, F., Pedone, P.V., Daniele, A., & Naviglio, S. (2017). Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells. Pulmonary Pharmacology and Therapeutics, 45, 114-120. https://doi.org/10.1016/j.pupt.2017.05.009
Lippi, G., Longo, U.G., & Maffulli, N. (2009). Genetics and sports. British Medical Bulletin, 93, 27-47.
Marclay, F., Mangin, P., Margot, P., & Saugy, M. (2013). Perscpetcives for Forensic Intelligence in anti-doping: Thinking outside of the box. Forensic Science International, 229, 133-144.
Mazzeo, F. (2016). Drug abuse in elite athletes: Doping in Sports. Sport Science, 9(2), 34-41.
Mazzeo, F. (2018). Anabolic steroid use in sports and in physical activity: Overview and analysis. Sport Mont, 16(3), 113-118. https://doi.org/10.26773/smj.181020
Mazzeo, F., & Raiola, G. (2018). An investigation of drugs abuse in sport performance. Journal of Human Sport and Exercise, 13, S309-S319. https://doi.org/10.14198/jhse.2018.13.Proc2.15
Mazzeo, F., Monda, M., Messina, G., Santamaria, S., Messina, A., Montesano, M., Monda, V. & Tafuri, D. (2016). Doping in Italy. An analysis of its spread in the last 10 years. Biol Med, 8(1), 1-9.
Mazzeo, F., Monda, V., Santamaria, S., Nigro, E., Valenzano, A., Villano, I., Cibelli, G., Messina, A., & Messina, G. (2018a). Antidoping program: An important factor in the promotion and protection of the integrity of sport and athlete’s health. Journal of Sports Medicine and Physical Fitness, 58(7-8), 1135-1145. https://doi.org/10.23736/S0022-4707.17.07722-2
Mazzeo, F., Santamaria, S., Iavarone, A. (2015). “Boosting” in paralympic athletes with spinal cord injury: Doping without drugs. Functional Neurology, 30(2), 91-98.
Mazzeo, F.& Volpe, R.A. (2016). From gene doping to athlete biological passport. Sport Science, 9(2), 97-103.
Møller, V. & Dimeo, P. (2014). Anti-doping – the end of sport. Int J Sport Policy Polit., 6, 259–272. https://doi.org/10.1080/19406940.2013.798740
Montesano, P., Tafuri, D., & Mazzeo, F. (2013). Improvement of the motor performance difference in athletes of weelchair Basketball. Journal of Physical Education and Sport, 13(3), 362-370.
Morente-Sánchez, J. & Zabala, M. (2013). Doping in sport: a review of elite athletes’ attitudes, beliefs, and knowledge. Sports Med; 43(6), 395-411.
Motola, G., Russo, F., Mazzeo, F., Rinaldi, B., Capuano, A., Rossi, F., & Filippelli, A. (2001). Over-the-counter oral nonsteroidal anti-inflammatory drugs: A pharmacoepidemiologic study in southern italy. Advances in Therapy, 18(5), 216-222. https://doi.org/10.1007/BF02853167
Oliveira, R.S., Collares, T.F., Smith, K.R., Collares, T.V., & Seixas, F.K. (2011). The use of genes for performance enhancement: doping or therapy? Braz J Medl Biol Res, 44(12), 1194-201.
Schenone, S., Bruno, O., Ranise, A., Brullo, C., Bondavalli, F., Filippelli, W., Mazzeo, F., Capuano, A., & Falcone, G. (2003). 2-aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity. Farmaco, 58(9), 845-849. https://doi.org/10.1016/S0014-827X(03)00142-3
Sjöqvist, F., Garle, M., Rane, A. (2008). Use of doping agents, particularly anabolic steroids, in sports and society Lancet, 31(371), 1872-1882. https://doi.org/10.1016/S0140-6736(08)60801-6.
Stella, L., D’Ambra, C., Mazzeo, F., Capuano, A., Del Franco, F., Avolio, A., & Ambrosino, F. (2005). Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients. Life Sci, 77(21), 2717-22.
Stubbe, J.H., Chorus, A.M.J., Frank, L.E., de Hon, O., & van der Heijden, P.G.M. (2014). Prevalence of use of performance enhancing drugs by fitness centre members. Drug Testing and Analysis, 6(5), 434-438. https://doi.org/10.1002/dta.1525
Valkenburg, D., de Hon, O,, van Hilvoorde, I. (2014) Doping control, providing whereabouts and the importance of privacy for elite athletes. Int J Drug Policy, 25, 212-218.
Zhang, K., Chen, X., Meng, J., & Chen, D. (2008). Effect of siRNA targeted against MKK4 on myostatin-induced downregulation of differentiation marker gene ex